New York State Common Retirement Fund’s Bicara Therapeutics BCAX Stock Holding History

New York State Common Retirement Fund’s Portfolio BCAX Stock Details BCAX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$460K	Buy	15,500 +8,000	+107%	+$179K	﹤0.01%	2039
2026 Q1	$149K	Hold	7,500	–	–	﹤0.01%	2350
2025 Q4	$126K	Buy	7,500 +3,500	+88%	+$59.8K	﹤0.01%	2504
2025 Q3	$63.2K	Sell	4,000 -22,094	-85%	-$247K	﹤0.01%	2871
2025 Q2	$242K	Buy	26,094 +22,094	+552%	+$263K	﹤0.01%	2171
2025 Q1	$52.1K	Buy	+4,000	New	+$53.1K	﹤0.01%	2758
2024 Q4	–	Sell	-17,227	Closed	-$439K	–	3190
2024 Q3	$439K	Buy	+17,227	New	+$439K	﹤0.01%	1983

Other funds holding BCAX

RTM

Red Tree Management Redwood City, California $147M AUM 202.18% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

NFT

Nan Fung Trinity Central, Hong Kong, Hong Kong $1.01B AUM 64.38% 1-Year Est. Return

Walleye Capital New York $28B AUM 44.22% 1-Year Est. Return

TD Asset Management Toronto, Ontario, Canada $115B AUM 41.58% 1-Year Est. Return

SAM

SEB Asset Management Stockholm $26.6B AUM

HealthInvest Partners Stockholm, Sweden $372M AUM 59.89% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

ALPS Advisors Denver, Colorado $21.3B AUM 23.41% 1-Year Est. Return

SCM

SCS Capital Management Boston, Massachusetts $10.6B AUM 19.73% 1-Year Est. Return

New York State Common Retirement Fund's BCAX Position: Q2 2026 in Review

New York State Common Retirement Fund increased its Bicara Therapeutics (BCAX) stake by 107% in Q2 2026, buying an estimated $179K and bringing the position to 15,500 shares worth $460K. The position accounts for ﹤0.01% of the portfolio, ranked #2039.

New York State Common Retirement Fund first reported a position in BCAX in Q3 2024 and has held it in 7 quarters since. 43 funds tracked by Wall St. Rank hold BCAX as of Q2 2026.

New York State Common Retirement Fund held 15,500 shares of Bicara Therapeutics worth $460K as of Q2 2026.
New York State Common Retirement Fund bought 8,000 Bicara Therapeutics shares in Q2 2026, an estimated $179K.
Bicara Therapeutics made up ﹤0.01% of New York State Common Retirement Fund's portfolio in Q2 2026, its #2039 holding.
New York State Common Retirement Fund first reported a position in Bicara Therapeutics in Q3 2024 and has held it in 7 quarters since.
43 funds tracked by Wall St. Rank held Bicara Therapeutics as of Q2 2026.

Based on New York State Common Retirement Fund's 13F filing for Q2 2026, filed 29 Jul 2026.